Literature DB >> 8568461

Interleukin-1 effect on glycemia in the non-obese diabetic mouse at the pre-diabetic stage.

A Amrani1, M Jafarian-Tehrani, P Mormède, S Durant, J M Pleau, F Haour, M Dardenne, F Homo-Delarche.   

Abstract

Cytokines, particularly interleukin 1 (IL-1) and tumor necrosis factor, are known to induce hypoglycemia in normal rodents or different experimental models of type II diabetes. We investigated, at the pre-diabetic stage, the effect of short-term administration of murine recombinant interleukin-1 alpha (mrIL-1 alpha) on the levels of glucose, insulin and corticosterone in the non-obese diabetic (NOD) mouse, a spontaneous model of type I diabetes. Two-month-old, pre-diabetic NOD mice of both sexes were insensitive to mrIL-1 alpha (12.5 and 50 micrograms/kg) 2 h after administration, the time at which the maximal decrease (around 50%) was observed in the C57BL/6 mouse strain. Kinetic studies however showed that mrIL-1 alpha lowered glycemia in both sexes of NOD mice, but the effect was limited and delayed. In the NOD and C57BL/6 strains, mrIL-1 alpha had no influence on insulin levels in females, but significantly increased them in males (P < 0.0001). Castration of NOD males abrogated the stimulatory effect of mrIL-1 alpha on insulin secretion. Corticosterone secretion was stimulated by mrIL-1 alpha in both sexes of NOD and C57BL/6 mice, and this effect was faster and greater in NOD females than in C57BL/6 females. The incomplete hypoglycemic response to mrIL-1 alpha in females may be attributed to the anti-insulin effect of glucocorticoids, an effect which can be demonstrated when mrIL-1 alpha is administered to adrenalectomized animals or when mrIL-1 alpha is administered together with the glucocorticoid antagonist RU38486. In NOD males, in contrast, glucocorticoids did not play a major role in the limited hypoglycemic response to mrIL-1 alpha, since RU38486 and adrenalectomy were not able to unmask a hypoglycemic effect. Moreover, NOD mice of both sexes were less sensitive than C57BL/6 mice to the hypoglycemic effect of insulin (2.5 U/kg), which suggests some degree of insulin-resistance in NOD mice. With regard to the effect of IL-1 on NOD mouse glycemia, therefore, these results suggest that glucocorticoids and/or androgens, according to the animal's sex, may induce a state of insulin-resistance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8568461     DOI: 10.1677/joe.0.1480139

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  13 in total

Review 1.  Mast cells and metabolic syndrome.

Authors:  Jie Zhang; Guo-Ping Shi
Journal:  Biochim Biophys Acta       Date:  2010-12-23

2.  Nonobese diabetic mice express aspects of both type 1 and type 2 diabetes.

Authors:  Rodolfo José Chaparro; Yves Konigshofer; Georg F Beilhack; Judith A Shizuru; Hugh O McDevitt; Yueh-Hsiu Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-08       Impact factor: 11.205

3.  Contribution of different mechanisms to pancreatic beta-cell hyper-secretion in non-obese diabetic (NOD) mice during pre-diabetes.

Authors:  Kuo Liang; Wen Du; Wenzhen Zhu; Shuang Liu; Yeqing Cui; Haichen Sun; Bin Luo; Yanhong Xue; Lu Yang; Liangyi Chen; Fei Li
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

Review 4.  Type 1 diabetes: translating mechanistic observations into effective clinical outcomes.

Authors:  Kevan C Herold; Dario A A Vignali; Anne Cooke; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2013-04       Impact factor: 53.106

5.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

Authors:  Haiyan Xu; Glenn T Barnes; Qing Yang; Guo Tan; Daseng Yang; Chieh J Chou; Jason Sole; Andrew Nichols; Jeffrey S Ross; Louis A Tartaglia; Hong Chen
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

6.  Bromocriptine-induced hyperglycemia in nonobese diabetic mice: kinetics and mechanisms of action.

Authors:  Sylvie Durant; Josiane Coulaud; Francoise Homo-Delarche
Journal:  Rev Diabet Stud       Date:  2007-11-10

7.  miR-146a-mediated suppression of the inflammatory response in human adipocytes.

Authors:  Julian Roos; Eveliina Enlund; Jan-Bernd Funcke; Daniel Tews; Karlheinz Holzmann; Klaus-Michael Debatin; Martin Wabitsch; Pamela Fischer-Posovszky
Journal:  Sci Rep       Date:  2016-12-06       Impact factor: 4.379

Review 8.  Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease.

Authors:  Jesús Burillo; Patricia Marqués; Beatriz Jiménez; Carlos González-Blanco; Manuel Benito; Carlos Guillén
Journal:  Cells       Date:  2021-05-18       Impact factor: 6.600

Review 9.  Human adipose dynamics and metabolic health.

Authors:  Bin Feng; Tracy Zhang; Haiyan Xu
Journal:  Ann N Y Acad Sci       Date:  2013-01-14       Impact factor: 5.691

Review 10.  Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.

Authors:  Un Ju Jung; Myung-Sook Choi
Journal:  Int J Mol Sci       Date:  2014-04-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.